Newly Approved Agent for Diffuse Midline Glioma Shows Tolerable AE Profile
Written by
Cancer Network
Published
0
comments
0
min
Dordaviprone was recommended at a dose of 625 mg orally once weekly for adults, and the recommended dosage is based on body weight for pediatric patients.